Navigation Links
Prostate Cancer Patients in US and Europe Receive Treatments Using Enhanced Seed Prostate Brachytherapy Software
Date:3/31/2009

Varian's VariSeed(TM) 8.0 Offers Advantages in Simplifying Dose Planning and Identifying Seed Positions, according to Clinicians

CHARLOTTESVILLE, Va., March 31 /PRNewswire-FirstCall/ -- Prostate cancer patients have begun receiving brachytherapy using new treatment planning software that enables improvements in the precision and speed of the treatment process. VariSeed(TM) 8.0 from Varian Medical Systems (NYSE: VAR) is an updated version of the company's market-leading treatment planning software for Low Dose Rate (LDR) brachytherapy in which radiation doses are delivered by implanting seeds within the prostate.

With VariSeed 8.0, doctors can use the new software to target individual sectors of the prostate based on biopsy results, according to Rebecca Claydon, software product manager with Varian's Brachytherapy business unit. "We have also speeded up the planning process considerably with an improved SeedFinder(TM) algorithm," Claydon said. "The use of a 3-D Digital Reconstructed Radiograph (DRR) generated from a CT allows doctors to more easily see and interactively add or remove proposed seed locations from the treatment plan."

According to Dr. William Bice, recently at the University of Texas Health Science Center at San Antonio but now practicing at The London Clinic in England, the main benefit of VariSeed 8.0 over previous versions of the product is its ability to perform sector analysis. "The new version of VariSeed features some significant improvements in several different areas, particularly the ability to target regions using sector analysis," said Dr. Bice. "It is now easier to verify seed locations following source localization and reconstruction using the projection display in VariSeed 8.0."

At Kuopio University Hospital in Finland, brachytherapy physicist Jan-Erik Palmgren carried out his first treatment using VariSeed 8.0 in March. "The ease of calibration was excellent and we are evaluating the benefits of sector analysis," he said. "Permanent seed implants are becoming more common in Finland. This is a small country and patients are asking for it because their friends tell them about it. It's very easy for the patient and the treatment is outpatient-based."

"There are some really nice features with VariSeed 8.0 that aid identification and simplify dose planning," says Asa Jamtrot, medical physicist at Karolinska University's South Hospital in Stockholm, Sweden. Doctors at the hospital have treated between 6 and 10 patients using the new system to date.

"It's extremely important to make the planning as easy as possible, particularly when you are in the operating room," Rebecca Claydon added. "Our customers have always liked the simple tabular flow of VariSeed which makes the system so usable, and the new digital connection to BK Medical's Pro Focus* scanner improves this workflow even more."

VariSeed 8.0 also offers brachytherapy physicists new and improved contouring tools, including the ability to contour in the sagittal and coronal planes. Contouring the urethra has been simplified by the introduction of the Structure sweep, which is also available in the VariSeed Implant View(TM) module for interactive seed placement and dosimetry. For post planning, the updated system offers a tool that creates a digital reconstruction of the CT image and makes it much simpler to define the seed placement, which has been time-consuming in the past. A typical permanent seed implant involves up to 120 radioactive seeds, each the size of a grain of rice.

Permanent Seed Implants

The use of permanent seed implants for LDR brachytherapy for early stage prostate cancer has increased in recent years. In this technique, radioactive seeds are positioned in the prostate using needles that are guided into position by ultrasound and a template or grid through which the needles are inserted to control their spacing. From 50 to more than 100 individual seeds may be placed in a single session, using 10 to 20 needles. The seeds or radiation sources then deliver the dose slowly over the following month.

There are more than 1,200 hospital sites worldwide using approximately 1,700 Varian VariSeed software systems for guiding the placement of permanent prostate seed implants in what is called LDR brachytherapy. Use of this technique alone or in combination with external beam radiotherapy is increasing for patients, including about 60,000, or one third, of U.S. men who are diagnosed annually with prostate cancer.

*Trademark of BK Medical

Editorial contact: Neil Madle, Varian Medical Systems, +44 7786 526068

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in North America and Europe and in its 79 sales and support offices around the world. For more information, visit http://www.varian.com/.


'/>"/>
SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wayne State University Scientists ID New Biomarker for Prostate Cancer
2. American Urological Association Statement in Support of Prostate-Specific Antigen Testing
3. A new approach to prostate cancer detection
4. Scientists ID New Biomarker for Prostate Cancer
5. Omega-3 Fatty Acids Guard Against Advanced Prostate Cancer
6. Omega-3 fatty acids reduce risk of advanced prostate cancer
7. AUDIO from Medialink and Mens Health Network: Important Decision Regarding Prostate Cancer
8. SPCG-4 trial: Update on watchful waiting versus radical prostatectomy
9. Castrate resistant prostate cancer: New therapeutic approaches
10. Free Community Seminar to Review Treatment Options for Enlarged Prostate
11. US trial shows no early mortality benefit from annual prostate cancer screening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution is underway. ... ambulance transport experience for the millions of people who require these medical transport ... taxi industry through the use of technology. Now, SmartEMS has put forth an ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... ALEXANDRIA, Va. , June 24, 2016 ... a set of recommendations that would allow ... information (HCEI) with entities that make formulary and coverage ... determine the "value" of new medicines. The ... that does not appear on the drug label, a ...
(Date:6/24/2016)... PUNE, India , June 24, 2016 ... "Pen Needles Market by Type (Standard Pen Needles, Safety ... 12mm), Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase ... published by MarketsandMarkets, This report studies the market for ... is expected to reach USD 2.81 Billion by 2021 ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced ... as its e-clinical software solution of choice.  This ... best possible value to their clients by offering ... The preferred relationship establishes nowEDC as the EDC ... for MedSource,s full-service clients.  "nowEDC has long been ...
Breaking Medicine Technology: